REDUCTION OF ERBB2 GENE-PRODUCT IN MAMMA CARCINOMA CELL-LINES BY ERBB2 MESSENGER-RNA-SPECIFIC AND TYROSINE KINASE CONSENSUS PHOSPHOROTHIOATE ANTISENSE OLIGONUCLEOTIDES

被引：49

作者：

BERTRAM, J ^{[1
]}

KILLIAN, M ^{[1
]}

BRYSCH, W ^{[1
]}

SCHLINGENSIEPEN, KH ^{[1
]}

KNEBA, M ^{[1
]}

机构：

[1] MAX PLANCK INST BIOPHYS CHEM,D-37075 GOTTINGEN,GERMANY

来源：

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS | 1994年 / 200卷 / 01期

关键词：

D O I：

10.1006/bbrc.1994.1499

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

A considerable reduction of up to 75% at the protein level of the erbB2 gene product was observed using phosphorothioate antisense oligonucleotides directed against specific sequences of the erbB2 mRNA. Antisense oligonucleotides used were the 14-mer (translation start region) and the 17-mer (3' translated region) all-phosphorothioate oligonucleotides (S-ODNs). Sense or random sequences were used as a control. The greatest reduction at the erbB2 protein level was obtained after a 24h incubation with a single dose of 2 mu M antisense S-ODN. The erbB2-mRNA-specific and the tyrosine kinase consensus antisense S-ODNs were comparably effective in inhibiting erbB2 expression. Addition of the transfection reagent DOTAP diminished the efficiency of erbB2 protein reduction by antisense S-ODNs after an incubation period of 24h but was more effective after 48h compared to the application of antisense S-ODNs alone. (C) 1994 Academic Press, Inc.

引用

页码：661 / 667

页数：7

共 20 条

[1] THE PRODUCT OF THE HUMAN C-ERBB-2 GENE - A 185-KILODALTON GLYCOPROTEIN WITH TYROSINE KINASE-ACTIVITY [J].

AKIYAMA, T ;

SUDO, C ;

OGAWARA, H ;

TOYOSHIMA, K ;

YAMAMOTO, T .

SCIENCE, 1986, 232 (4758) :1644-1646

[2]

BENNETT CF, 1992, MOL PHARMACOL, V41, P1023

[3]

BORG A, 1991, ONCOGENE, V6, P137

[4] OLIGONUCLEOTIDES AS THERAPEUTIC AGENTS [J].

COHEN, JS .

PHARMACOLOGY & THERAPEUTICS, 1991, 52 (02) :211-225

[5] TYROSINE KINASE RECEPTOR WITH EXTENSIVE HOMOLOGY TO EGF RECEPTOR SHARES CHROMOSOMAL LOCATION WITH NEU ONCOGENE [J].

COUSSENS, L ;

YANGFENG, TL ;

LIAO, YC ;

CHEN, E ;

GRAY, A ;

MCGRATH, J ;

SEEBURG, PH ;

LIBERMANN, TA ;

SCHLESSINGER, J ;

FRANCKE, U ;

LEVINSON, A ;

ULLRICH, A .

SCIENCE, 1985, 230 (4730) :1132-1139

[6] A C-MYB ANTISENSE OLIGODEOXYNUCLEOTIDE INHIBITS NORMAL HUMAN HEMATOPOIESIS INVITRO [J].

GEWIRTZ, AM ;

CALABRETTA, B .

SCIENCE, 1988, 242 (4883) :1303-1306

[7]

Lofts F J, 1992, Cancer Treat Res, V61, P161

[8]

MCMANAWAY ME, 1991, NUCLEIC ACIDS RES, V19, P945

[9] ANTISENSE C-MYC EFFECTS ON PREIMPLANTATION MOUSE EMBRYO DEVELOPMENT [J].

PARIA, BC ;

DEY, SK ;

ANDREWS, GK .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (21) :10051-10055

[10] BCL2-MEDIATED TUMORIGENICITY OF A HUMAN T-LYMPHOID CELL-LINE - SYNERGY WITH MYC AND INHIBITION BY BCL2 ANTISENSE [J].

REED, JC ;

CUDDY, M ;

HALDAR, S ;

CROCE, C ;

NOWELL, P ;

MAKOVER, D ;

BRADLEY, K .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (10) :3660-3664

← 1 2 →